Donepezil Dosing for Dementia
Start donepezil at 5 mg once daily in the evening, then increase to 10 mg daily after 4-6 weeks for all patients with dementia due to Alzheimer's disease. For patients with moderate to severe disease who have been stable on 10 mg for at least 3 months, consider escalation to 23 mg daily if additional benefit is needed.
Initial Dosing Strategy
The FDA-approved dosing schedule is clear and should be followed systematically 1:
- Starting dose: 5 mg once daily in the evening, just prior to bedtime
- Timing of dose increase: After 4-6 weeks on 5 mg, increase to 10 mg once daily
- Administration: Can be taken with or without food, though taking with food reduces gastrointestinal side effects 2
This gradual titration approach is critical because adverse events—particularly nausea, vomiting, and diarrhea—occur more frequently when doses are escalated too quickly 2, 3.
Disease Severity-Based Dosing
Mild to Moderate Alzheimer's Disease
- Maximum recommended dose: 10 mg daily 1
- This dose provides clinically meaningful improvements in cognition and global function 2, 4
- Evidence shows a dose-response relationship, with 10 mg superior to 5 mg for cognitive outcomes 4
Moderate to Severe Alzheimer's Disease
- Start with the same 5 mg → 10 mg titration schedule
- After at least 3 months on 10 mg daily, may increase to 23 mg daily 1
- The 23 mg dose shows particular benefit for language and visuospatial ability in advanced disease 5
- Important: The 23 mg tablet must not be split, crushed, or chewed 1
Optimizing Tolerability During Dose Escalation
A critical pitfall is escalating too rapidly to higher doses. Recent evidence demonstrates that intermediate dose titration significantly reduces cholinergic side effects 3:
- When escalating from 10 mg to 23 mg, consider either:
- 15 mg daily for 4 weeks before going to 23 mg, OR
- Alternating 10 mg and 23 mg daily for 4 weeks
- Direct escalation to 23 mg causes significantly more nausea compared to titrated approaches 3
Monitoring and Duration
Assessment of response requires 6-12 months of observation 2. Brief mental status tests are relatively insensitive to donepezil's effects, so use:
- Physician global assessment
- Caregiver reports of function and behavior
- Formal neuropsychological testing when available
The benefits are modest but real: donepezil produces approximately a 7-point improvement on neuropsychologic tests, equivalent to delaying one year's decline 2. This represents a 5-15% benefit over placebo 2.
When to Discontinue
Discontinue donepezil if 2:
- Side effects develop and persist despite dose reduction
- Poor medication adherence
- Deterioration continues at the pre-treatment rate after 6-12 months
- Patient develops severe/end-stage dementia with complete dependence in basic ADLs 6
Important exception: Do not discontinue in patients with active psychotic symptoms, agitation, or aggression until these stabilize, as cholinesterase inhibitors can help manage these symptoms 6.
Common Pitfalls to Avoid
- Escalating dose too quickly: Always wait the full 4-6 weeks before increasing from 5 mg to 10 mg 1
- Splitting the 23 mg tablet: This formulation is sustained-release and must be swallowed whole 1
- Expecting dramatic improvements: Set realistic expectations with patients and families—benefits are modest but meaningful 2
- Premature discontinuation: Give adequate time (6-12 months) to assess response 2
- Ignoring drug interactions: Monitor patients on cimetidine, theophylline, warfarin, or digoxin more closely 2
Special Considerations
- No hepatotoxicity: Unlike tacrine, donepezil does not require liver function monitoring 2
- Once-daily dosing: The long half-life (60-104 hours) supports convenient once-daily administration 7
- Renal impairment: Use cautiously in dialysis patients; consider starting at 2.5 mg daily in severe renal impairment 8
- Initial agitation: Some patients experience increased agitation in the first few weeks, which typically subsides with continued treatment 2